Decreased FGF19 and FGF21: possible underlying common pathogenic mechanism of metabolic and cognitive dysregulation in depression
BackgroundAccumulating studies suggested that major depressive disorder (MDD) was closely related to metabolic syndrome (MetS). Important endogenous regulators fibroblast growth factors (FGFs) 19 and 21 were also reported to participate in psychiatric disorders. This study aimed to investigate the r...
Main Authors: | Mimi Tang, Shuqiao Cheng, Lu Wang, Hui Tang, Ting Liu, Tingyu Zhao, Ruili Dang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2023.1165443/full |
Similar Items
-
The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients
by: Aneta Cymbaluk-Płoska, et al.
Published: (2020-06-01) -
Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho
by: Alexandra S. Aaldijk, et al.
Published: (2023-05-01) -
Epigallocatechin-3-gallate ameliorates hepatic damages by relieve FGF21 resistance and promotion of FGF21–AMPK pathway in mice fed a high fat diet
by: Yuanyuan Zhang, et al.
Published: (2022-04-01) -
Clinical significance of serum FGF21 levels in diagnosing nonalcoholic fatty liver disease early
by: Kai Xu, et al.
Published: (2024-10-01) -
The role of FGF21 and its analogs on liver associated diseases
by: Kimia Falamarzi, et al.
Published: (2022-11-01)